CN1319569C - Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof - Google Patents
Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof Download PDFInfo
- Publication number
- CN1319569C CN1319569C CNB2004100730778A CN200410073077A CN1319569C CN 1319569 C CN1319569 C CN 1319569C CN B2004100730778 A CNB2004100730778 A CN B2004100730778A CN 200410073077 A CN200410073077 A CN 200410073077A CN 1319569 C CN1319569 C CN 1319569C
- Authority
- CN
- China
- Prior art keywords
- radix
- powder
- myrrha
- borax
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 91
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 127
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 48
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 48
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 47
- 229910021538 borax Inorganic materials 0.000 claims abstract description 46
- 239000004863 Frankincense Substances 0.000 claims abstract description 45
- 229940079593 drug Drugs 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 238000010298 pulverizing process Methods 0.000 claims abstract description 10
- 241001057584 Myrrha Species 0.000 claims description 45
- 239000004328 sodium tetraborate Substances 0.000 claims description 45
- 241000717739 Boswellia sacra Species 0.000 claims description 44
- 239000009286 sanguis draxonis Substances 0.000 claims description 43
- 241000371997 Eriocheir sinensis Species 0.000 claims description 34
- 239000011812 mixed powder Substances 0.000 claims description 33
- 241000628997 Flos Species 0.000 claims description 32
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 27
- 239000012535 impurity Substances 0.000 claims description 21
- -1 Pyritum Substances 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000021419 vinegar Nutrition 0.000 claims description 9
- 239000000052 vinegar Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 claims description 3
- 238000005282 brightening Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 52
- 210000004369 blood Anatomy 0.000 abstract description 52
- 210000000988 bone and bone Anatomy 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 20
- 210000003734 kidney Anatomy 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 15
- 208000027418 Wounds and injury Diseases 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 206010052428 Wound Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 239000011028 pyrite Substances 0.000 abstract description 2
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052683 pyrite Inorganic materials 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 abstract 1
- 208000010392 Bone Fractures Diseases 0.000 description 23
- 206010017076 Fracture Diseases 0.000 description 22
- 210000003205 muscle Anatomy 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 16
- 238000005728 strengthening Methods 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 13
- 208000014674 injury Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical class NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LKAJKIOFIWVMDJ-IYRCEVNGSA-N Stanazolol Chemical compound C([C@@H]1CC[C@H]2[C@@H]3CC[C@@]([C@]3(CC[C@@H]2[C@@]1(C)C1)C)(O)C)C2=C1C=NN2 LKAJKIOFIWVMDJ-IYRCEVNGSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011207 functional examination Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000009040 gushukang Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- NPAGDVCDWIYMMC-IZPLOLCNSA-N nandrolone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 NPAGDVCDWIYMMC-IZPLOLCNSA-N 0.000 description 2
- 229960004719 nandrolone Drugs 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229960000912 stanozolol Drugs 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072985 Spinal column fractures Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940062527 alendronate Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical class OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000003339 pneumostatic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Material name | Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | Example 6 | Example 7 | Example 8 | Example 9 | Example 10 | Example 11 | Example 12 |
Radix Dipsaci | 7.5 | 2.0 | 4.5 | 3.5 | 6.5 | 5.5 | 2.5 | 5.0 | 5.0 | 5.0 | 3.0 | 5.0 |
Radix Notoginseng | 17.5 | 13.5 | 16.5 | 14.0 | 17.5 | 15.5 | 12.0 | 15.0 | 15.0 | 14.5 | 13.0 | 17.0 |
Borax | 4.5 | 7.5 | 2.0 | 3.5 | 4.0 | 5.5 | 2.0 | 3.0 | 5.0 | 5.0 | 6.5 | 2.5 |
Sanguis Draxonis | 17.5 | 12.0 | 13.5 | 16.5 | 17.0 | 14.5 | 12.0 | 16.0 | 15.0 | 14.5 | 15.5 | 14.0 |
Rhizoma Drynariae | 5.5 | 2.0 | 3.5 | 4.5 | 6.5 | 7.5 | 2.5 | 3.0 | 5.0 | 4.0 | 6.0 | 5.0 |
Pyritum | 3.0 | 3.5 | 4.5 | 5.5 | 7.5 | 6.5 | 2.5 | 2.0 | 5.0 | 4.0 | 2.5 | 5.0 |
The Cortex Eucommiae | 0.0 | 3.5 | 4.5 | 6.5 | 0.0 | 2.0 | 5.5 | 2.5 | 4.0 | 3.5 | 7.5 | 5.0 |
Radix Glycyrrhizae | 2.0 | 3.0 | 2.5 | 3.5 | 0.0 | 4.0 | 3.5 | 0.0 | 3.5 | 3.0 | 2.5 | 3.0 |
The Eriocheir sinensis powder | 7.5 | 6.0 | 7.0 | 6.5 | 0.0 | 6.0 | 6.0 | 7.0 | 7.5 | 6.5 | 0.0 | 6.5 |
Radix Rehmanniae Preparata | 3.5 | 5.5 | 4.5 | 2.0 | 5.0 | 7.5 | 3.0 | 6.5 | 4.0 | 4.0 | 6.0 | 2.5 |
Radix Angelicae Sinensis | 3.5 | 4.5 | 5.5 | 2.0 | 6.5 | 2.0 | 7.5 | 3.0 | 4.0 | 4.0 | 2.5 | 5.0 |
Rhizoma Chuanxiong | 2.0 | 3.5 | 6.5 | 4.5 | 3.0 | 2.5 | 2.5 | 7.5 | 4.0 | 4.0 | 3.0 | 5.5 |
Cortex Acanthopancis | 4.5 | 3.5 | 2.0 | 5.5 | 7.5 | 3.0 | 6.5 | 2.0 | 4.0 | 4.0 | 2.5 | 4.0 |
The Radix Paeoniae Alba | 2.0 | 7.5 | 3.5 | 2.0 | 4.5 | 2.0 | 6.5 | 2.5 | 4.0 | 4.0 | 5.5 | 4.0 |
Olibanum | 2.5 | 3.5 | 5.5 | 3.5 | 4.5 | 3.0 | 7.5 | 2.5 | 3.0 | 4.0 | 6.5 | 2.0 |
Myrrha | 3.5 | 7.5 | 2.0 | 4.5 | 2.5 | 5.5 | 2.0 | 6.5 | 3.0 | 4.0 | 2.5 | 3.0 |
Flos Carthami | 2.5 | 3.5 | 4.5 | 5.5 | 2.0 | 2.0 | 6.5 | 7.5 | 3.0 | 4.0 | 2.5 | 3.0 |
Radix Paeoniae Rubra | 3.5 | 4.5 | 5.5 | 2.0 | 3.0 | 2.0 | 3.0 | 6.5 | 3.0 | 4.0 | 7.5 | 2.5 |
Radix Et Rhizoma Rhei | 7.5 | 3.5 | 2.0 | 4.5 | 2.5 | 3.5 | 6.5 | 2.0 | 3.0 | 4.0 | 5.0 | 5.5 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100730778A CN1319569C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100730778A CN1319569C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1669577A CN1669577A (en) | 2005-09-21 |
CN1319569C true CN1319569C (en) | 2007-06-06 |
Family
ID=35041153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100730778A Active CN1319569C (en) | 2004-09-10 | 2004-09-10 | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319569C (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100626358B1 (en) * | 2005-01-20 | 2006-09-21 | 주식회사 오스코텍 | Herbal mixture extract of Notoginseng Radix, Rehmanniae Radix Preparata and Acanthopanacis Cortex and composition comprising the same for prevention and treatment of arthritis |
CN101129448B (en) * | 2006-08-21 | 2012-04-25 | 兰州大得利生物化学制药(厂)有限公司 | Compositions for preventing and controlling climacteric syndrome and osteoporosis, and processes for producing the same |
CN101032614B (en) * | 2007-04-05 | 2010-05-26 | 赵子山 | Chinese traditional composition for curing slow concrescence or non-concrescence of fracture and the preparing method |
CN101317942B (en) * | 2008-07-21 | 2010-09-22 | 刘皇琼 | Bone-setting alcohol |
CN101991736B (en) * | 2010-11-08 | 2012-01-25 | 李景禄 | Medicament for treating osteopathy |
CN102579734B (en) * | 2011-11-28 | 2013-04-24 | 陕西宏府怡悦制药有限公司 | Traditional Chinese medicine composition of bone healing medicine, preparing method thereof and detecting method thereof |
CN102670805B (en) * | 2012-05-15 | 2013-06-05 | 张化 | Ointment for treating bone diseases |
CN103830770B (en) * | 2014-03-12 | 2015-11-18 | 青岛市黄岛区中医医院 | A kind of wound site medicine antibacterial antiinflammatory dressing |
CN104001004A (en) * | 2014-06-16 | 2014-08-27 | 徐艳 | Traditional Chinese medicine composition for curing fractures and osteoporosis and preparation method and application thereof |
CN104147288A (en) * | 2014-08-12 | 2014-11-19 | 潘阿海 | Traditional Chinese medicine with the effects of soothing channels and invigorate blood circulation |
CN104491114A (en) * | 2014-12-30 | 2015-04-08 | 陈满锦 | Novel application of traditional Chinese medicine composition |
CN105796739A (en) * | 2015-08-04 | 2016-07-27 | 烟台市华文欣欣医药科技有限公司 | Method for preparing traditional Chinese medicinal composition for treating geriatric fracture |
CN105879093A (en) * | 2016-04-07 | 2016-08-24 | 永春县达埔彬达制香厂有限公司 | Dark agilawood having functions of calming nerves and promoting sleep and preparation method of dark agilawood |
EP3903798A1 (en) * | 2020-04-27 | 2021-11-03 | Lulin Wang | Bone-strengthening pill (bsp) as a dietary supplement to improve blood circulation and strengthen bone and muscle |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079152A (en) * | 1992-05-28 | 1993-12-08 | 杨应和 | Preparation method of quick-acting bone injury medicine |
CN1134286A (en) * | 1995-04-28 | 1996-10-30 | 冯文光 | Zhuangguning-medicine for bone fracture |
-
2004
- 2004-09-10 CN CNB2004100730778A patent/CN1319569C/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079152A (en) * | 1992-05-28 | 1993-12-08 | 杨应和 | Preparation method of quick-acting bone injury medicine |
CN1134286A (en) * | 1995-04-28 | 1996-10-30 | 冯文光 | Zhuangguning-medicine for bone fracture |
Also Published As
Publication number | Publication date |
---|---|
CN1669577A (en) | 2005-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1814247A (en) | Chinese medicine bone-setting ointment and preparing method | |
CN1319569C (en) | Chinese medicine preparation for treating osteoporosis and fracture and preparation process thereof | |
CN1939491A (en) | Chinese medicinal herbs for treating spur and its preparation | |
CN101732521B (en) | Medicinal composition for treating fracture and preparation method thereof | |
CN1285374C (en) | Medicine for treating stomachache caused by qi and cold stagnation and technique for preparing the same | |
CN1712054A (en) | Qinchuan Tongbi tablet | |
CN1133450C (en) | Medicine for preventing and curing asteoporosis and promoting union and its production method | |
CN1927331A (en) | Chinese medicine preparation for curing chronic heart failure | |
CN1840160A (en) | Powder for resisting hyperosteogeny | |
CN1640451A (en) | Medicinal composition for relieving itching | |
CN1272055C (en) | Chinese materia medica preparation of prolonging life for invigorating the kidney yang and producing method | |
CN102283917B (en) | Deer bone medicated liquor for treating fracture | |
CN104352718A (en) | Medicine for treating osteoporosis and preparation method thereof | |
CN1261137C (en) | Chinese medicine preparation bone setting powder for treating traumatic injury | |
CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
CN115844972B (en) | Navel patch for treating osteoporosis and preparation method thereof | |
CN1089602C (en) | Medicinal composition for treating bone fracture and its preparing process | |
CN1814163A (en) | Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method | |
CN1225277C (en) | Chinese medicinal composition for treating epilepsy disease and its preparation method | |
CN1243565C (en) | Traditional Chinese medicine pain-relieving bag | |
CN1201810C (en) | Chinese medicine for treating asynodia | |
CN1413653A (en) | Chinese drugs for treating cardiovascular and cerebrovascular system disease and its preparation method | |
CN1432374A (en) | Kidney asthenia treating medicine and its prepn process | |
CN1887331A (en) | Fracture setting medicine powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANXI HONGFU YIYUE PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHAANXI YIYUE PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: No. 18, No. six West end, science and technology zone, Xi'an hi tech Zone, Shaanxi Patentee after: Shaanxi Hongfuyiyue Pharmaceutical Co., Ltd. Address before: No. 18, west end of science and technology road, hi tech Zone, Shaanxi, Xi'an Patentee before: Shaanxi Yiyue Pharmaceutical Co., Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: SHAANXI WEIXIN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: 8HONGFU YIYUE PHARMACEUTICAL CO., LTD., SHAANXI |
|
CP01 | Change in the name or title of a patent holder |
Address after: 710065, No. 18, west end, six, hi tech Zone, Shaanxi, Xi'an Patentee after: Shaanxi Weixin Pharmaceutical Co., Ltd. Address before: 710065, No. 18, west end, six, hi tech Zone, Shaanxi, Xi'an Patentee before: Shaanxi Hongfuyiyue Pharmaceutical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHAANXI HAIPU MEDICINE CO., LTD. Free format text: FORMER OWNER: SHAANXI WEIXIN PHARMACEUTICAL CO., LTD. Effective date: 20150316 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710065 XI'AN, SHAANXI PROVINCE TO: 714000 WEINAN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150316 Address after: 714000 Weinan province hi tech Zone, Weibei Industrial Park Road, No., Wei Wei Road, No. 1 Patentee after: SHAANXI HAIPU PHARMACEUTICAL CO., LTD. Address before: 710065, No. 18, west end, six, hi tech Zone, Shaanxi, Xi'an Patentee before: Shaanxi Weixin Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 714000 Weinan province hi tech Zone, Weibei Industrial Park Road, No., Wei Wei Road, No. 1 Patentee after: Shaanxi tiandirenhe Pharmaceutical Co. Ltd. Address before: 714000 Weinan province hi tech Zone, Weibei Industrial Park Road, No., Wei Wei Road, No. 1 Patentee before: SHAANXI HAIPU PHARMACEUTICAL CO., LTD. |